Evidence map›Paper›PMID 34244665›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Biallelic variants in PCDHGC4 cause a novel neurodevelopmental syndrome with progressive microcephaly, seizures, and joint anomalies.

Maria Iqbal, Reza Maroofian, Büşranur Çavdarlı, Florence Riccardi, Michael Field, Siddharth Banka, Dalal K Bubshait, Yun Li, Jozef Hertecant, Shahid Mahmood Baig and 44 more

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synaptic gene expression changes in frontotemporal dementia due to themedRxiv : the preprint server for health sciences · 2024
    Article
  8. Article
  9. The clustered gamma protocadherin PcdhγC4 isoform regulates cortical interneuron programmed cell death in the mouse cortex.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. A Unique Role for Protocadherin γC3 in Promoting Dendrite Arborization through an Axin1-Dependent Mechanism.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  11. Identification of two novel autism genes,Frontiers in psychiatry · 2023
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors.

Maria Iqbal *Cologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Reza Maroofian *Department of Neuromuscular Disorders, UCL Institute of Neurology, London, UK.
Büşranur Çavdarlı *Department of Medical Genetics, Ankara Bilkent City Hospital, Ankara, Turkey.
Florence Riccardi *Aix Marseille Univ, INSERM, MMG, Marseille, France.
Michael Field *Genetics of Learning Disability Service, Hunter Genetics, Waratah, NSW, Australia.
Siddharth BankaManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Dalal K BubshaitDepartment of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Yun LiInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Jozef HertecantPaediatric Genetic and Metabolic Service, Tawam Hospital, Al Ain, United Arab Emirates.
Shahid Mahmood BaigHuman Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.
David DymentChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
Stephanie EfthymiouDepartment of Neuromuscular Disorders, UCL Institute of Neurology, London, UK.
Uzma AbdullahUniversity Institute of Biochemistry and Biotechnology (UIBB), PMAS-Arid Agriculture University, Rawalpindi, Pakistan.
Ehtisham Ul Haq MakhdoomCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Zafar AliCentre for Biotechnology and Microbiology, University of Swat, Swat, Pakistan.
Tobias Scherf de AlmeidaInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Florence MolinariAix Marseille Univ, INSERM, MMG, Marseille, France.
Cécile Mignon-RavixAix Marseille Univ, INSERM, MMG, Marseille, France.
Brigitte ChabrolAssistance Publique-Hôpitaux de Marseille, APHM, Hôpital Timone Enfants, Service de Neurologie Pédiatrique, Marseille, France.
Jayne AntonyT.Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Sydney, Australia.
Lesley AdesSpecialty of Child and Adolescent Health and Discipline of Genomic Medicine, The Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, Australia.
Alistair T PagnamentaNational Institute for Health Research Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Adam JacksonManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Sofia DouzgouManchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Genomics England Research Consortium
Christian BeetzCENTOGENE GmbH, Rostock, Germany.
Vasiliki KarageorgouCENTOGENE GmbH, Rostock, Germany.
Barbara VonaDepartment of Otolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre (THRC), Eberhard Karls University Tübingen, Tübingen, Germany.
Aboulfazl RadDepartment of Otolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre (THRC), Eberhard Karls University Tübingen, Tübingen, Germany.
Jamshaid Mahmood BaigDepartment of Bioinformatics & Biotechnology, Faculty of Basic and Applied Sciences, International Islamic University, Islamabad, Pakistan.
Tipu SultanDepartment of Pediatric Neurology, Children's Hospital and Institute of Child Health, Lahore, Pakistan.
Javeria Raza AlviDepartment of Pediatric Neurology, Children's Hospital and Institute of Child Health, Lahore, Pakistan.
Shazia MaqboolDevelopment and Behavioural Pediatrics Department, Institute of Child Health and The Children Hospital, Lahore, Pakistan.
Fatima RahmanDevelopment and Behavioural Pediatrics Department, Institute of Child Health and The Children Hospital, Lahore, Pakistan.
Mehran Beiraghi ToosiPediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Farah AshrafzadehPediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Shima ImannezhadPediatric Neurology Department, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Ehsan Ghayoor KarimianiMolecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London, UK.
Yasra SarwarHuman Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.
Sheraz KhanHuman Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.
Muhammad JameelHuman Molecular Genetics Laboratory, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE) College, PIEAS, Faisalabad, Pakistan.
Angelika A NoegelInstitute of Biochemistry I, Medical Faculty, University of Cologne, Cologne, Germany.
Birgit BuddeCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Janine AltmüllerCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Susanne MotamenyCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Wolfgang HöhneCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Henry HouldenDepartment of Neuromuscular Disorders, UCL Institute of Neurology, London, UK.
Peter NürnbergCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany.
Bernd WollnikInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
Laurent VillardAix Marseille Univ, INSERM, MMG, Marseille, France.
Fowzan Sami AlkurayaDepartment of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Matthew OsmondChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
Muhammad Sajid HussainCologne Center for Genomics (CCG), University of Cologne and University Hospital Cologne, Cologne, Germany. mhussain@uni-koeln.de.
Gökhan YigitInstitute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany. goekhan.yigit@med.uni-goettingen.de.ORCID http://orcid.org/0000-0003-2777-0198

Funding

Medical Research Council G0601943Medical Research Council MC_EX_MR/M009203/1Medical Research Council MR/M009203/1Medical Research Council MR/S005021/1Medical Research Council MR/S01165X/1Wellcome Trust
6 · The paper itself

Abstract

purposeWe aimed to define a novel autosomal recessive neurodevelopmental disorder, characterize its clinical features, and identify the underlying genetic cause for this condition.

methodsWe performed a detailed clinical characterization of 19 individuals from nine unrelated, consanguineous families with a neurodevelopmental disorder. We used genome/exome sequencing approaches, linkage and cosegregation analyses to identify disease-causing variants, and we performed three-dimensional molecular in silico analysis to predict causality of variants where applicable.

resultsIn all affected individuals who presented with a neurodevelopmental syndrome with progressive microcephaly, seizures, and intellectual disability we identified biallelic disease-causing variants in Protocadherin-gamma-C4 (PCDHGC4). Five variants were predicted to induce premature protein truncation leading to a loss of PCDHGC4 function. The three detected missense variants were located in extracellular cadherin (EC) domains EC5 and EC6 of PCDHGC4, and in silico analysis of the affected residues showed that two of these substitutions were predicted to influence the Ca

conclusionWe show that biallelic variants in PCDHGC4 are causing a novel autosomal recessive neurodevelopmental disorder and link PCDHGC4 as a member of the clustered PCDH family to a Mendelian disorder in humans.

Indexed as

Intellectual DisabilityMicrocephalyNeurodevelopmental DisordersCadherin Related ProteinsCadherinsHumansPedigreePhenotypeSeizuresCadherin Related ProteinsCadherinsGamma-protocadherins

Identifiers

PMID34244665
PMCPMC8553613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.